Broadridge Financial Solutions

BR Net selling

CIK 0001383312 #78 in the set updated 17 Sep 2026

Bought (120 mo)

$1.03M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$755.21M

$8.67M on a plan · $645.75M straight out of an exercise

Sold at will

$100.78M

73 of 366 sales

Net

−$754.17M

−$99.75M against sales at will

By person

35 insiders · 381 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

DALY RICHARD J

Executive Chairman

—

$249.89M (57) scheduled

−$249.89M

242,803

0.2129%

$37.63M

−57.4%

Gokey Timothy C

CEO

$1.03M (1)

$139.49M (25) scheduled

−$138.46M

176,141

0.1545%

$27.30M

+186.2%

PERRY CHRISTOPHER JOHN

President

—

$66.99M (42) scheduled

−$66.99M

54,137

0.0475%

$8.39M

+116.6%

SCHIFELLITE ROBERT

Corporate SVP

—

$63.60M (30) scheduled

−$63.60M

123,576

0.1084%

$19.15M

+49.0%

DESCHUTTER DOUGLAS RICHARD

Co-President ICS

$1.25K (1)

$58.92M (25) scheduled

−$58.92M

18,047

0.0158%

$2.80M

−69.5%

Young James M

Corporate SVP and CFO

—

$28.31M (12) scheduled

−$28.31M

16,598

0.0146%

$2.57M

−32.4%

AMSTERDAM ADAM D

CVP and Sr. Advisor to the CEO

—

$19.79M (20) scheduled

−$19.79M

11,397

0.0100%

$1.77M

−52.1%

Carey Thomas P

Corporate VP

—

$19.39M (21) scheduled

−$19.39M

11,301

0.0099%

$1.75M

+554.8%

Mayadas Vijay

Corporate Vice President

—

$13.72M (13) scheduled

−$13.72M

30,555

0.0268%

$4.74M

+370.5%

KALENKA ROBERT F

Corporate Vice President

—

$11.32M (11) scheduled

−$11.32M

26,867

0.0236%

$4.16M

−28.8%

Liberatore Michael

VP, ICS - Mutual Funds

—

$10.91M (10) scheduled

−$10.91M

6,052

0.0053%

$938.02K

−37.9%

Levine Stuart R

Director

—

$10.51M (6) scheduled

−$10.51M

46,594

0.0409%

$7.22M

+116.3%

PERNA THOMAS J

Director

—

$10.21M (10) scheduled

−$10.21M

30,061

0.0264%

$4.66M

+76.0%

Taylor Julie R.

Corporate VP and CHRO

—

$9.82M (13) scheduled

−$9.82M

14,073

0.0123%

$2.18M

—

Matlin Laura

CVP, Deputy GC and CCO

—

$7.97M (17) scheduled

−$7.97M

6,343

0.0056%

$983.09K

+14.1%

BRUN LESLIE A

Director

—

$7.02M (10) scheduled

−$7.02M

77,433

0.0679%

$12.00M

+343.3%

Tae Michael S

Corporate VP, CTO, ICS

—

$6.17M (5) scheduled

−$6.17M

8,057

0.0071%

$1.25M

—

Duelks Robert N

Director

—

$5.02M (13) scheduled

−$5.02M

38,085

0.0334%

$5.90M

+4,971%

MARCHESANI CHARLES J

Corporate Vice President

—

$4.03M (3) scheduled

−$4.03M

18,128

0.0159%

$2.81M

−45.1%

Markus Maura A.

Director

—

$3.34M (4) scheduled

−$3.34M

32,718

0.0287%

$5.07M

+407.6%

Haviland Richard J

Director

—

$3.01M (4) scheduled

−$3.01M

47,900

0.0420%

$7.42M

+88.9%

keller brett

Director

—

$1.31M (2) scheduled

−$1.31M

16,968

0.0149%

$2.63M

+863.5%

Carter Pamela L

Director

—

$1.17M (2) scheduled

−$1.17M

7,282

0.0064%

$1.13M

—

Gumbs Keir D

CVP and Chief Legal Officer

—

$1.17M (2) scheduled

−$1.17M

14,403

0.0126%

$2.23M

+39,931%

WEBER ALAN J

Director

—

$1.02M (4) scheduled

−$1.02M

74,464

0.0653%

$11.54M

+290.3%

Jarkowski Hope M.

Chief Legal Officer

—

$813.56K (3)

−$813.56K

1

<0.0001%

$193.74

0.0%

Stingi Richard John

Corporate VP and CHRO

—

$304.30K (2)

−$304.30K

7,681

0.0067%

$1.19M

+158.2%

Dampeer Lyell

Corporate Vice President

—

—

—

18,709

0.0164%

$2.90M

+8.5%

Nazareth Annette L.

Director

—

—

—

9,614

0.0084%

$1.49M

—

Zavery Amit

Director

—

—

—

9,011

0.0079%

$1.40M

+180,120%

Reese Edmund

Corporate VP and CFO

—

—

—

7,491

0.0066%

$1.16M

+14,273%

Ghei Ashima

CFO

—

—

—

6,027

0.0053%

$934.15K

+94.3%

MURRAY EILEEN K

Director

—

—

—

5,758

0.0050%

$892.46K

—

FLOWERS MELVIN L

Director

—

—

—

2,694

0.0024%

$417.56K

—

Mosconi Patricia Ann

Director

—

—

—

641

0.0006%

$99.35K

+6,310%

Individual transactions

2

Insider

Date

Role

Action

Shares

Price

Amount

Gokey Timothy C

6 Mar 2026

CEO

Buy

5,300

$194.49

$1.03M

DESCHUTTER DOUGLAS RICHARD

25 Feb 2020

Corporate Vice President

Buy

11

$113.33

$1.25K

Showing 250 of 381 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 1,150

Amendments (4/A) skipped 22

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 289

Sales at will 73

Transactions with no price 0

Shares from compensation/vesting 7,050,387

Sales filed before the plan box existed 45

History held since 31 Aug 2016